<DOC>
	<DOCNO>NCT02712957</DOCNO>
	<brief_summary>The purpose study ass NEO6860 , modality selective TRPV1 antagonist , patient pain associated osteoarthritis knee .</brief_summary>
	<brief_title>A Proof-of-Concept Study Assessing NEO6860 Osteoarthritis Pain</brief_title>
	<detailed_description>The study randomize , double blind , placebo active control , 3-way , 3-period crossover design , estimate 50 enrolled patient receive alternately ( ) NEO6860 ( 500 mg bid ) , ( ii ) placebo ( iii ) Naproxen ( 500 mg bid ) . To ensure blinding , double dummy technique use , period , patient receive oral liquid suspension ( NEO6860 placebo ) one capsule ( naproxen placebo ) . Following screening period , maximum 28 day dose , subject randomize one schedule sequence . At dose period , subject request participate 2 clinic visit : - One residential visit , morning investigational product dosing . Subjects stay Clinical Research Unit approximately 13 hour - One end period visit , 24 h first dose A total 2 washout period 1 3 week separate dose period . Once 3 dose period complete , subject come back clinic follow visit ( 7 10 day post last dose ) . Note : subpopulation , one site , assessment heat pain threshold tolerance conduct require residential period approximately 24 hour .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Body mass index ( BMI ) 18.0 35.0 kg/m2 inclusive ; Patients diagnose osteoarthritis knee , accord American College Rheumatology ( ACR ) guideline , meet least 3 follow : age &gt; 50 , morning stiffness &lt; 30 minute , crepitus active motion , bone tenderness , bone enlargement , palpable warmth synovium ; Grade I , II III use KellgrenLawrence classification XRay knee WOMAC pain subscale â‰¥ 8 R square Focused Analgesia Selection Task ( FAST ) outcome value great 0.70 Patients , history , clinically significant disorder ( include fibromyalgia painful disorder ) may interfere primary objective study Patients treat previous 3 month topical capsaicin intraarticular corticosteroid ; Patients contraindication use Naproxen acetaminophen ;</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>